Yin, Xianyong https://orcid.org/0000-0001-6454-2384
Li, Jack
Bose, Debraj https://orcid.org/0000-0002-3177-6608
Okamoto, Jeffrey https://orcid.org/0000-0001-9988-1618
Kwon, Annie
Jackson, Anne U. https://orcid.org/0000-0002-9672-2547
Fernandes Silva, Lilian https://orcid.org/0000-0003-0225-842X
Oravilahti, Anniina https://orcid.org/0000-0001-8866-4482
Chu, Xiaomeng
Stringham, Heather M. https://orcid.org/0000-0002-2991-6392
Liu, Lei
Peng, Ruyi
Xia, Zhijie
Ripatti, Samuli https://orcid.org/0000-0002-0504-1202
Daly, Mark
Palotie, Aarno https://orcid.org/0000-0002-2527-5874
Scott, Laura J. https://orcid.org/0000-0002-4886-5084
Burant, Charles F. https://orcid.org/0000-0001-9189-5003
Fauman, Eric B. https://orcid.org/0000-0002-9739-0249
Wen, Xiaoquan https://orcid.org/0000-0001-8990-2737
Boehnke, Michael https://orcid.org/0000-0002-6442-7754
Laakso, Markku https://orcid.org/0000-0002-3394-7749
Morrison, Jean https://orcid.org/0000-0003-4829-8283
Funding for this research was provided by:
American Diabetes Association (1-19-PDF-061)
Article History
Received: 19 June 2023
Accepted: 10 March 2025
First Online: 28 March 2025
Competing interests
: E.B.F. is an employee and stockholder of Pfizer. The remaining authors declare no competing interests.